Member Spotlight: Q&A with bluebird bio


Every month, MassBio spotlights a member company and its efforts in advancing the life sciences industry and supporting the patients we serve. In April, we profile bluebird bio and speak with Tom Klima, chief commercial and operating officer of the Somerville-based gene therapy company. Tom, who joined bluebird in May 2021, has deep passion for patients and experience across multiple commercial roles in both rare diseases and oncology.

bluebird custom designs each of its investigational therapies with the goal of addressing the underlying cause of disease at the genetic level. bluebird is currently developing gene therapies for severe genetic diseases and is advancing research to apply new technologies to these and other diseases. More than 170+ patients have received bluebird’s therapies across 8 clinical trials.

The post Member Spotlight: Q&A with bluebird bio appeared first on Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks